Aging Population and Unhealthy Foods Habits to Boost the Sales of Radiopharmaceuticals REQUEST FOR SAMPLE REPORT Buy Now Request For sample Report × Report Title Name Email Designation Phone No Comapny Name Comapny URL Country -- Please Select Your Country -- Afganistan Africa Albania Algeria Andorra Angola Anguilla Antigua and Barbuda Argentina Armenia Aruba Asia Australasia Australia Austria Azerbaijan Bahamas Bahrain Bangladesh Barbados Belarus Belgium Belize Benin Bermuda Bhutan Bolivia Bonaire Bosnia Herzegovina Botswana Brazil BRICS British Virgin Islands Brunei Darussalam Bulgaria Burkina Faso Cambodia Cameroon Canada Cape Verde Cayman Islands Central African Republic Central and South America Chad Chile China Colombia Comoros Congo Costa Rica Cote d'Ivoire Croatia Cuba Curacao Cyprus Czech Republic Denmark Djibouti Dominica Dominican Republic Ecuador Egypt El Salvador Equatorial Guinea Eritrea Estonia Ethiopia Europe European Union Falkland Islands Faroe Islands Fiji Finland France French Guiana French Polynesia Gabon Gambia Georgia Germany Ghana Gibraltar Global Great Britain Greece Greenland Grenada Guadeloupe Guam Guatemala Guerney & Alderney Guinea Guinea-Bissau Guyana Haiti Honduras Hong Kong Hungary Iceland India Indonesia Iran Iraq Ireland Isle of Man Israel Italy Ivory Coast Jamaica Japan Jersey Jordan Kazakhstan Kenya Kiribati Kosovo Kuwait Kyrgyzstan Laos Latvia Lebanon Lesotho Liberia Libyan Arab Jamahiriya Liechtenstein Lithuania Luxembourg Macao Macau Macedonia Madagascar Malawi Malaysia Maldives Mali Malta Man (Island of) Marshall Islands Martinique Mauritania Mauritius Mayotte Mexico Micronesia Middle East Minnesota Moldova Monaco Mongolia Monserrat Montenegro Morocco Morroco Mozambique Myanmar Namibia Nepal Netherlands New Caledonia New Zealand Nicaragua Niger Nigeria Niue North America North Korea Norway Oman Pakistan Palau Palestine Panama Papua New Guinea Paraguay Peru Philippines Poland Portugal Puerto Rico Qatar Reunion Romania Russia Rwanda Saint Helena Saint Lucia Saint Martin Saint Pierre and Miquelon Saint Vincent and the Grenadines Samoa Samoa (American) San Marino Sao Tome and Principe Saudi Arabia Scandinavia Senegal Serbia Seychelles Sierra Leone Singapore Sint Maarten Slovakia Slovenia Solomon (Islands) Somalia South Africa South Korea South Sudan Spain Sri Lanka Sudan Suriname Svalbard and Jan Mayen Islands Swaziland Sweden Switzerland Syria Taiwan Tajikistan Tanzania Thailand Timor Leste Togo Tonga Trinidad and Tobago Tunisia Turkey Turkmenistan Turks and Caicos Islands Uganda Ukraine United Arab Emirates United Kingdom United States Uruguay Uzbekistan Vanuatu Vatican City Venezuela Vietnam Virgin Islands Western Sahara Yemen Zambia Zimbabwe Requirement Submit A radiopharmaceutical is a radioactive compound or drug, used for the diagnosis and therapeutic treatment of human diseases. Gallium Citrate Ga 67, Sodium Fluoride F 18, Technetium Tc 99m Disofenin, Indium In 111 Pentetreotide, Technetium Tc 99m Arcitumomab are some examples of the radiopharmaceutical. Radiopharmaceutical has two components; radionuclide and pharmaceutical. It is a compound manufactured for use as a medicinal drug, for instance, Prozac. They can be inserted into a vein, taken by mouth or placed in a body cavity. These are used in various diseases like blood volume studies, abscess & infection, blood vessel diseases of the brain, bone diseases and biliary tract blockage etc. Radiopharmaceuticals can be divided into four categories, are radiopharmaceutical preparation, radionuclide generator, radiopharmaceutical precursor and kit for radiopharmaceutical preparation. A radiopharmaceutical preparation is a medicinal product, suitable for human use which contains a radionuclide, used for one or more diagnostic or therapeutic applications. According to study, “Global Radiopharmaceutical Market Research Report – Forecast To 2023” some of the companies that are working in radiopharmaceutical are Bicron, ANSTO, Capintec, Dupoint, CORPUS, BC technical Inc., Digirad, IZOTOP, GE healthcare, MEDASYS, Inderlec medical systems, Pharmex, Nuclide navigator lite, SMV nuclear medicine company, Segami, international, Schiller America, Toshiba medical system, Radiopharmaceutical dispensing recommends dosage level based on patient history, age, weight and surface area etc. Dispensing also develops policies & procedures to ensure that the correct drug in the correct dosage & dosage form is received by the correct patient at the correct time by a correct route of administration. Whereas distribution of it complies with all applicable regulations concerning packaging, labeling & transportation of radioactive and other materials. The advantages of radiopharmaceutical include diagnosis and treatment of a patient, availability of modes, provide fast onset of pain relief, single dose effect, cost-effective and no side effect etc. There are some disadvantages of radiopharmaceutical such as radiation risk, allergic reaction, prolonged inconvenience &discomfort, occurring myelosuppression etc. Radiopharmaceutical market is segmented in various terms. On the basis of application, the market is segmented into cardiology, oncology, neurology, and thyroid. On the basis of modality, a market is segmented into PET, alpha-emitters, beta-emitters, SPECT, and brachytherapy. On the basis of type, a market is segmented into diagnostic and therapeutic. On the basis of end-user, the market is segmented into hospitals & diagnostic centers and research institutes. On the basis of the type of test, the market is segmented into lung scan, bone scan, gallium scan, white blood cell scan, renal nuclear scan, parathyroid scans, and hepatobiliary scans. On the basis of the route of administration, the market is segmented into intravenous and intravitreal. The global radiopharmaceutical market was valued at US$5.2 billion in 2017 and is estimated to reach US$7.4 billion by 2024, expanding at a CAGR of 5.4% from 2017 to 2024. North America is the most attractive regional market in the global radiopharmaceuticals market. The growth in the region is expected to continue with the technological improvements in PET scanning devices. The other factor impacting the global radiopharmaceuticals market is the rising prevalence of cancer. This has significantly increased the number of nuclear medicine procedures performed in the region and is on the specific reason that the market for radiopharmaceuticals is steadily growing in North America. There have been a rising number of cardiovascular diseases among the people in North America due to the aging population, unhealthy food habits and rising obesity. The increasing number of cardiovascular patients is expected to boost the sales of radiopharmaceuticals, which would eventually create growth in the global radiopharmaceuticals market. To know more, click on the link below: Global Radiopharmaceutical Market Research Report – Forecast To 2023 Contact Us: Ken Research Ankur Gupta, Head Marketing & Communications sales@kenresearch.com +91-9015378249 Post Views: 3 Tags: Radiopharmaceutical Market Analysis, Radiopharmaceutical Market Applications, Radiopharmaceutical Market Forecast, Radiopharmaceutical Market Growth Analysis, Radiopharmaceutical Market Imports and Exports, Radiopharmaceutical Market Leading Players, Radiopharmaceutical Market Opportunities, Radiopharmaceutical Market Overview, Radiopharmaceutical Market Research Report, Radiopharmaceutical Market Research Statistics, Radiopharmaceutical Market Segmentation, Radiopharmaceutical Market Size, Radiopharmaceutical Market Trends, Radiopharmaceutical Market Value, Radiopharmaceutical Marketing Competitive Analysis